(Q44424103)

2 December 2017

title

Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin (English)

1 reference

2 December 2017

0 references

Robert Sarnovsky

1

1 reference

2 December 2017

Tara Tendler

2

1 reference

2 December 2017

Matheusz Makowski

3

1 reference

2 December 2017

Maureen Kiley

4

1 reference

2 December 2017

Antonella Antignani

5

1 reference

2 December 2017

Roberta Traini

6

1 reference

2 December 2017

Jingli Zhang

7

1 reference

2 December 2017

Raffit Hassan

8

1 reference

2 December 2017

David J FitzGerald

9

1 reference

2 December 2017

publication date

29 November 2009

1 reference

Cancer Immunology, Immunotherapy

2 December 2017

published in

1 reference

2 December 2017

volume

59

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

737-746

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-009-0794-4

2 December 2017

exact match

0 references

cites work

Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00262-009-0794-4

Treatment of solid tumors with immunotoxins

21 January 2018

1 reference

12 December 2020

Recent trends in targeted anticancer prodrug and conjugate design

1 reference

12 December 2020

Monoclonal antibodies in therapy of solid tumors

1 reference

12 December 2020

Antibody-drug conjugates for cancer therapy

1 reference

12 December 2020

An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes

1 reference

12 December 2020

Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies

1 reference

12 December 2020

Trastuzumab--mechanism of action and use in clinical practice

1 reference

12 December 2020

A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies

1 reference

12 December 2020

A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin

1 reference

12 December 2020

Technology insight: cytotoxic drug immunoconjugates for cancer therapy

1 reference

12 December 2020

Novel radiolabeled antibody conjugates

1 reference

12 December 2020

Engineering therapeutic monoclonal antibodies

1 reference

12 December 2020

Analysis of Pseudomonas exotoxin activation and conformational changes by using monoclonal antibodies as probes

1 reference

12 December 2020

Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15-deoxyspergualin in mice.

1 reference

12 December 2020

A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma

1 reference

12 December 2020

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia

1 reference

12 December 2020

B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice

1 reference

12 December 2020

Immunotoxin therapy of hematologic malignancies

1 reference

12 December 2020

Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin’s lymphoma

1 reference

12 December 2020

Pretargeted radioimmunotherapy for B-cell lymphomas

1 reference

12 December 2020

Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers

1 reference

12 December 2020

Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients

1 reference

12 December 2020

Renaturation of a single-chain immunotoxin facilitated by chaperones and protein disulfide isomerase

1 reference

12 December 2020

A survey of furin substrate specificity using substrate phage display

1 reference

12 December 2020

A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity.

1 reference

12 December 2020

Immunotoxins in the treatment of refractory hairy cell leukemia

1 reference

12 December 2020

Characterization of Vibrio cgolerae non-O1 serogroups obtained from an outbreak of diarrhea in Lima, Peru.

1 reference

12 December 2020

Immunotoxin treatment of cancer

1 reference

12 December 2020

Immunotoxin therapy of cancer

1 reference

12 December 2020

Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy

1 reference

12 December 2020

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

1 reference

12 December 2020

A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors

1 reference

12 December 2020

Antibody-onconase conjugates: cytotoxicity and intracellular routing

1 reference

12 December 2020

A glimpse into the expanded genome content of Vibrio cholerae through identification of genes present in environmental strains

1 reference

12 December 2020

Pretreatment with rituximab does not inhibit the human immune response against the immunogenic protein LMB-1

1 reference

12 December 2020

Mechanism of action of Pseudomonas exotoxin. Identification of a rate-limiting step.

1 reference

12 December 2020

Reducing the immune response to immunotoxin

1 reference

12 December 2020

Treatment with immunotoxin.

1 reference

12 December 2020

1 reference

12 December 2020

Cholix toxin, a novel ADP-ribosylating factor from Vibrio cholerae

1 reference

12 December 2020

10.1007/S00262-009-0794-4

Identifiers

DOI

1 reference

2 December 2017

0 references

1 reference